News & Articles

Explore comprehensive serological & PCR assays for vaccine-preventable disease detection

Carriers of two copies of the APOE ε4 allele have an increased risk of adverse reaction

Euroimmun and IDS offer a complete solution for easy and reliable allergy diagnostics

Candida auris (C.auris) infections are a major global health challenge, with nosocomial outbreaks on the rise and many strains exhibiting resistance to antifungal agents. New real-time PCR tests enable sensitive and specific identification of the pathogen and of the most important mutations associated with resistance to echinocandins (ECH).

More than 60 neural autoantibodies can be determined using a unique portfolio of tests from Euroimmun, including many novel and exclusive parameters

Euroimmun offers a range of CE-marked ELISAs for determination of intrathecal antibodies in cerebrospinal fluid samples

Euroimmun's test portfolio allows for qualified two-tiered Lyme disease diagnostics according to current recommendations

Measurement of anti-S1/RBD antibodies, neutralizing antibodies targeting S1/RBD, and specific T-cells using Euroimmun tests supports evaluation of the immune reaction to SARS-CoV-2 following vaccination or infection

CE marked assay based on well-established ELISA technology expands Euroimmun's offerings for labs that seek to understand immune response to COVID-19

Novel test supports vaccine development studies critical to aiding researchers in understanding immunity levels and disease progression

Automatable and reliable COVID-19 test rounds out company's menu of offerings for acute diagnostics of the virus